Impact of patient outcomes and cost aspects on reimbursement recommendations in Poland in 2012–2014

Krzysztof Piotr Malinowski, Paweł Kawalec and Wojciech Trąbka

Health Policy, 2016, vol. 120, issue 11, 1249-1255

Abstract: The aim of this study was to assess the influence of different factors on the final reimbursement recommendations for drugs in Poland and to identify the correlation between these factors and the probability of a positive reimbursement recommendation for an applicant drug issued by the President of the Agency for Health Technology Assessment and Tariff System (AOTMiT).

Keywords: Agency for Health Technology Assessment and Tariff System; AOTMiT; Reimbursement recommendations; Health technology assessment; Poland (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851016302469
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:120:y:2016:i:11:p:1249-1255

DOI: 10.1016/j.healthpol.2016.09.016

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().